Apixaban Chemical Structure (Apixaban Struct)
Eliquis Tablet, Film Coated
Product Images NDC 50090-6451
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eliquis (NDC 50090-6451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aristotle Forest Plot (Eliquis Clin Forest Fig5)
Aristotle Major Bleeding Forest Plot (Eliquis Forest Fig1)
This appears to be a table with various subgroups of patients, different treatments (apixaban and warfarin), and hazard ratios and confidence intervals. The text includes percentages of patients in each subgroup and their yearly events, such as bleeding and stroke. There is also information on geographic region and other factors that may affect treatment outcomes.*
Aristotle Kaplan-meier Curve (Eliquis Km Fig4)
Effect Of Coadministered Drugs On Pharmacokinetics Of Apixaban (Eliquis Pkplot Drugs Fig2)
This appears to be a table displaying the interactions between various drugs and P-gp and CYP3A4 inhibitors and inducers. The table shows the fold change and 90% confidence intervals for drug pharmacokinetics (PK) when combined with these inhibitors/inducers. The drugs listed include ketoconazole, glarithromycin, diltiazem, naproxen, and rifampin. The table also includes the relative change in PK compared to a reference drug.*
O:\e-submissions\pbo\products\eliquis 202155\08. Pas Esrd Dosing\01. Orig Submission\source\eliquis-pkplot-pop-fig3.jpg (Eliquis Pkplot Pop Fig3)
This text appears to be a medical record or clinical study table. It provides information about the normal and impaired renal function in patients, age groups, body weight, and hepatic impairment. It also provides a table of fold change and 90% CI for different conditions, along with recommended dosing adjustments.*
Label Image (Lbl500906451)
This is a product description for a medicine with the product number 9930-0. The name of the product is not clear due to poor quality. The medicine comes in the form of tablets with a strength of 2.5 mg. The storage temperature should be at 6870 7 degrees Celsius. There are 60 tablets in each package.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
